Prefrontal cortex Homer expression in an animal model of attention-deficit/hyperactivity disorder

Journal of the Neurological Sciences

Volumn 287, Issue 1-2, 2009, Pages 205-211

  Hong, Qin ^a   Zhang, Min ^a   Pan, Xiao qin ^a   Guo, Mei ^a   Li, Fei ^a   Tong, Mei ling ^a   Chen, Rong hua ^a   Guo, Xi rong ^a   Chi, Xia ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Attention deficit hyperactivity disorder (ADHD); Homer; Methylphenidate (MPH); Spontaneous hypertensive rat (SHR)

Indexed keywords

MESSENGER RNA; METHYLPHENIDATE; PROTEIN HOMER 1A; PROTEIN HOMER 1B; PROTEIN HOMER 1C; PROTEIN HOMER 2; PROTEIN HOMER 2A; PROTEIN HOMER 2B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DRUG MECHANISM; LOCOMOTION; MAZE TEST; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; UPREGULATION; WESTERN BLOTTING; WISTAR KYOTO RAT;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOTTING, WESTERN; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; METHYLPHENIDATE; PREFRONTAL CORTEX; PROTEIN ISOFORMS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 70449523329     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.07.024     Document Type: Article

References (48)

1. Katragadda S., and SH. ADHD in children, adolescents, and adults. Prim Care 34 2 (2007) 317-341
2. Castellanos F.X., Giedd J.N., Marsh W.L., Hamburger S.D., Vaituzis A.C., Dickstein D.P., et al. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53 (1996) 607-616
3. Castellanos F.X., and Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci 3 (2002) 617-628
4. Sullivan R.M., and Brake W.G. What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function. Behav Brain Res 146 (2003) 43-55
5. Russell V.A. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat. Behav Brain Res 130 (2002) 191-196
6. Arnsten A.F., and Dudley A.G. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav Brain Funct 1 (2005) 2
7. Mostofsky S.H., Cooper K.L., Kates W.R., Denckla M.B., and Kaufmann W.E. Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 52 8 (2002) 785-794
8. Tekin S., and Cummings J.L. Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res 53 2 (2002) 647-654
9. Brakeman P.R., Lanahan A.A., O'Brien R., Roche K., Barnes C.A., Huganir R.L., et al. Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386 (1997) 284-288
10. Xiao B., Tu J.C., Petralia R.S., Yuan J.P., Doan A., Breder C.D., et al. Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related synaptic proteins. Neuron 21 (1998) 707-716
11. Lominac K.D., Oleson E.B., Pava M., Klugmann M., Schwarz M.K., Seeburg P.H., et al. Distinct roles for different Homer 1 isoforms in behaviors and associated prefrontal cortex function. J Neurosci 25 50 (Dec 14, 2005) 11,586-11,594
12. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24 (2000) 31-39
13. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1239-1247
14. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol 58 (1992) 103-112
15. Wultz B., Sagvolden T., Moser E.I., and Moser M.B. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav Neural Biol 53 (1990) 88-102
16. Ueno K., Togashi H., and Yoshioka M. Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder. Nihon Shinkei Seishin Yakurigaku Zasshi 23 (2003) 47-55
17. Hunziker M.H., Saldana R.L., and Neuringer A. Behavioral variability in SHR and WKY rats as a function of rearing environment and reinforcement contingency. J Exp Anal Behav 65 (1996) 129-144
18. Adriani W., Caprioli A., Granstrem O., Carli M., and Laviola G. The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 27 (2003) 639-651
19. Sagvolden T., Pettersen M.B., and Larsen M.C. Spontaneously hypertensive rats (SHR) as a putative animal model of childhood hyperkinesis: SHR behavior compared to four other rat strains. Physiol Behav 54 (1993) 1047-1055
20. Wiersema J.R., van der Meere J.J., and Roeyers H. ERP correlates of impaired error monitoring in children with ADHD. J Neural Transm 112 (2005) 1417-1430
21. Printz M.P., JM, and Jaworski R. Genetic models in applied physiology. HXB/BXH rat recombinant inbred strain platform: a newly enhanced tool for cardiovascular, behavioral, and developmental genetics and genomics. J Appl Physiol 94 (2003) 2510-2522
22. Gaytan O., Ghelani D., Martin S., Swann A., and Dafny N. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Res 727 1-2 (Jul 15, 1996) 13-21
23. Aspide R., Fresiello A., de Filippis G., Gironi Carnevale U.A., and Sadile A.G. Non-selective attention in a rat model of hyperactivity and attention deficit: subchronic methylphenydate and nitric oxide synthesis inhibitor treatment. Neurosci Biobehav Rev 24 1 (Jan 2000) 59-71
24. Pietrzak R.H., Mollica C.M., Maruff P., and Snyder P.J. Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 30 8 (2006) 1225-1245
25. Capp P.K., Pearl P.L., and Conlon C. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder. Expert Rev Neurotherapeutics 5 3 (May 2005) 325-331
26. Greenhill L., Beyer D.H., Finkleson J., Shaffer D., Biederman J., Conners C.K., et al. Guidelines and algorithms for the use of methylphenidate in children with attention-deficit/hyperactivity disorder. J Atten Disord 6 Suppl 1 (2002) S89-S100
27. Yano M., and Steiner H. Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132 3 (2005) 855-865
28. Yano M., Beverley J.A., and Steiner H. Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects. Neuroscience 140 2 (Jun 30, 2006) 699-709
29. Szumlinski K.K., Dehoff M.H., Kang S.H., Frys K.A., Lominac K.D., Klugmann M., et al. Homer proteins regulate sensitivity to cocaine. Neuron 43 3 (Aug 5, 2004) 401-413
30. Szumlinski K.K., Ary A.W., Lominac K.D., Klugmann M., and Kippin T.E. Accumbens Homer 2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacology 33 6 (May 2008) 1365-1378
31. Carlsson M.L. On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 25 1 (Jan 2001) 5-26
32. Gainetdinov R.R., Mohn A.R., Bohn L.M., and Caron M.G. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci U S A 98 20 (Sep 25, 2001) 11,047-11,054
33. Russell V.A. Dopamine hypofunction possibly results from a defect in glutamatestimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder-the spontaneously hypertensive rat. Neurosci Biobehav Rev 27 (2003) 671-682
34. Kane J.K., Hwang Y., and Konu O. Regulation of Homer and group I metabotropic glutamate receptors by nicotine. Eur J Neurosci 21 5 (Mar 2005) 1145-1154
35. Szumlinski K.K., Lominac K.D., Oleson E.B., Walker J.K., Mason A., Dehoff M.H., et al. Homer 2 is necessary for EtOH-induced neuroplasticity. J Neurosci 25 30 (Jul 27, 2005) 7054-7061
36. Zhang G.C., Mao L.M., Liu X.Y., Parelkar N.K., Anish A., Yang L., et al. In vivo regulation of Homer 1a expression in the striatum by cocaine. Mol Pharmacol 71 4 (2007) 1148-1158
37. Koh S., Chung H., Xia H., et al. Environmental enrichment reverses the impaired exploratory behavior and altered gene expression induced by early-life seizures. J Child Neurol 20 10 (2005) 796-802
38. Inoue Y., Udo H., Inokuchi K., and Sugiyama H. Homer 1a regulates the activity-induced remodeling of synaptic structures in cultured hippocampal neurons. Neuroscience 150 4 (2007) 841-852
39. Kalivas P.W., Szumlinski K.K., and Worley P. Homer 2 gene deletion in mice produces a phenotype similar to chronic cocaine treated rats. Neurotox Res 6 5 (2004) 385-387
40. Szumlinski K.K., Abernathy K.E., Oleson E.B., et al. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology 31 4 (2006) 768-777
41. Xiao B., Tu J.C., and Worley P.F. Homer: a link between neural activity and glutamate receptor function. Curr Opin Neurobiol 10 3 (Jun 2000) 370-374
42. Fagni L., Worley P.F., and Ango F. Homer as both a scaffold and transduction molecule. Sci STKE 137 (Jun 18, 2002) RE8
43. Tu J.C., X.B., Yuan J.P., Lanahan A.A., Leoffert K., Li M., et al. Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 21 (1998) 717-726
44. Hwang S.Y., WJ, Westhoff J.H., Duncan R.S., Ozawa F., Volpe P., et al. Differential functional interaction of two vesl/homer protein isoforms with ryanodine receptor type 1: a novel mechanism for control of intracellular calcium signaling. Cell Calcium 34 (2003) 177-184
45. Feng W., TJ, Yang T., Vernon P.S., Allen P.D., Worley P.F., et al. Homer regulates gain of ryanodine receptor type 1 channel complex. J Biol Chem 277 (2002) 44,722-44,730
46. Yuan J.P., KK, Shin D.M., Chen J., Shcheynikov N., Kang S.H., et al. Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. Cell 114 (2003) 777-789
47. Naisbitt S., KE, Tu J.C., Xiao B., Sala C., Valtschanoff J., et al. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23 (1999) 569-582
48. Tu J.C., XB, Naisbitt S., Yuan J.P., Petralia R.S., Brakeman P., et al. Coupling of mGluR/Homer and PSD-95 complexes by the shank family of postsynaptic density proteins. Neuron 23 (1999) 583-592